These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 35847022)

  • 1. Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer.
    Liu X; Zhang Y; Wu X; Xu F; Ma H; Wu M; Xia Y
    Front Pharmacol; 2022; 13():909821. PubMed ID: 35847022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay.
    Zhang H; Chen N; Ding C; Zhang H; Liu D; Liu S
    Front Oncol; 2024; 14():1344290. PubMed ID: 38469234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance.
    Ren Y; Mao X; Xu H; Dang Q; Weng S; Zhang Y; Chen S; Liu S; Ba Y; Zhou Z; Han X; Liu Z; Zhang G
    Cell Mol Life Sci; 2023 Aug; 80(9):263. PubMed ID: 37598126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance.
    Cai J; Xu X; Saw PE
    Sci China Life Sci; 2024 Jan; 67(1):19-40. PubMed ID: 37728804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the relationship between ferroptosis and epithelial-mesenchymal transition in cancer.
    Mu W; Zhou Z; Shao L; Wang Q; Feng W; Tang Y; He Y; Wang Y
    Front Oncol; 2023; 13():1257985. PubMed ID: 38023171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy.
    Ebrahimi N; Adelian S; Shakerian S; Afshinpour M; Chaleshtori SR; Rostami N; Rezaei-Tazangi F; Beiranvand S; Hamblin MR; Aref AR
    Cytokine Growth Factor Rev; 2022 Apr; 64():33-45. PubMed ID: 35219587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance.
    Zhang C; Liu X; Jin S; Chen Y; Guo R
    Mol Cancer; 2022 Feb; 21(1):47. PubMed ID: 35151318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis in Cancer Progression.
    Zhang R; Chen J; Wang S; Zhang W; Zheng Q; Cai R
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis: A New Promising Target for Ovarian Cancer Therapy.
    Zhao H; Xu Y; Shang H
    Int J Med Sci; 2022; 19(13):1847-1855. PubMed ID: 36438923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of ferroptosis in head and neck cancer: A novel bridgehead for fighting cancer resilience.
    Lee J; Roh JL
    Cancer Lett; 2022 Oct; 546():215854. PubMed ID: 35973621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Macrophage-Ferroptosis Crosstalk: A Novel Insight into Tumor Immunotherapy.
    Zhou Z; Xu B; Hu N; Guo Z; Bao W; Shao B; Yang W
    Front Biosci (Landmark Ed); 2022 Jun; 27(7):203. PubMed ID: 35866391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-mesenchymal plasticity: Implications for ferroptosis vulnerability and cancer therapy.
    Lee J; Roh JL
    Crit Rev Oncol Hematol; 2023 May; 185():103964. PubMed ID: 36931615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy.
    Yin W; Chang J; Sun J; Zhang T; Zhao Y; Li Y; Dong H
    J Mater Chem B; 2023 Feb; 11(6):1171-1190. PubMed ID: 36650960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis: a novel strategy to overcome chemoresistance in gynecological malignancies.
    Xu J; Zheng B; Wang W; Zhou S
    Front Cell Dev Biol; 2024; 12():1417750. PubMed ID: 39045454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ferroptosis for cancer therapy: exploring novel strategies from its mechanisms and role in cancers.
    Jiang M; Qiao M; Zhao C; Deng J; Li X; Zhou C
    Transl Lung Cancer Res; 2020 Aug; 9(4):1569-1584. PubMed ID: 32953528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches.
    Cheng X; Zhao F; Ke B; Chen D; Liu F
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy.
    Xing N; Du Q; Guo S; Xiang G; Zhang Y; Meng X; Xiang L; Wang S
    Cell Death Discov; 2023 Apr; 9(1):110. PubMed ID: 37005430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression.
    Zhang X; Wang L; Li H; Zhang L; Zheng X; Cheng W
    Cell Death Dis; 2020 Jul; 11(7):580. PubMed ID: 32709863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer.
    Chen B; Zhao L; Yang R; Xu T
    Front Genet; 2023; 14():1275154. PubMed ID: 38028615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunometabolism of ferroptosis in the tumor microenvironment.
    Lupica-Tondo GL; Arner EN; Mogilenko DA; Voss K
    Front Oncol; 2024; 14():1441338. PubMed ID: 39188677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.